| | 
Part, Chapter, Paragraph
1 I, 2. 10. 2| include molecular diagnostic, imaging, drug discovery and drug
2 I, 2. 10. 2| various colours. Used for cell imaging, in particular in cancer
3 I, 2. 10. 2| in particular in cancer imaging:~- Nanorods: nanoparticles
4 I, 2. 10. 2| length, used in medicine as imaging and contrast agents;~- Polymer
5 II, 5. 2.Acr| Lipoprotein~MRI~Magnetic Resonance Imaging~PTCA~Percutaneous Transluminal
6 II, 5. 2. 2| and Magnetic Resonance Imaging [MRI]).~ ~
7 II, 5. 5. 3| clinical, laboratory and imaging data of each enrolled patient.
8 II, 5. 5. 3| incorporating magnetic resonance imaging (MRI), eliminating the category
9 II, 5. 5. 3| Sclerosis~MRI~Magnetic Resonance Imaging~MS~Multiple Sclerosis~MS-ID~
10 II, 5. 7. 1| renal tubular syndromes)~imaging abnormalities~• kidney transplantation~
11 II, 5. 8. 5| examination, lung function tests, imaging techniques and clinical
12 III, 10. 3. 1| MRI~Magnetic Resonance Imaging~SCENIHR~Scientific Committee
13 III, 10. 3. 1| MRI (Magnetic Resonance Imaging) equipment require risk
|
|
| |